Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × NSCLC × aumolertinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 NSCLC 1

Interventions

Paclitaxel 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 osimertinib 1 aumolertinib 1 Taxes 1 Pemetrexed 1 Gemcitabine 1 Clinical Trials, Phase I as Topic 1 Cisplatin 1 Cetuximab 1 BID protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05493501 2024-05-02

Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer

EQRx International, Inc.

Phase 3 Terminated

8 enrolled 7 charts

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡